Recordati Industria Chimica e Farmaceutica SPA (IT:REC) has released an update.
Recordati S.p.A. has successfully concluded its share buyback program, purchasing nearly 1.5 million shares at an average price of €50.03, totaling approximately €74.73 million. This move supports the company’s stock option and incentive plans for its management team. Recordati continues to expand its international presence, offering a wide range of therapeutic options.
For further insights into IT:REC stock, check out TipRanks’ Stock Analysis page.
Trending Articles
- Netflix (NASDAQ:NFLX) Celebrates Two Years with Ads, 70 Million on Board
- Verizon (NYSE:VZ) Suffers Massive Outage
- Shopify (TSE:SHOP) Surges after Stellar Earnings and Holiday Projections
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
